FDA.reportPublic FDA data

Application 207384

Type
ANDA
Sponsor
GLAND PHARMA LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DEFEROXAMINE MESYLATEDEFEROXAMINE MESYLATEINJECTABLE;INJECTION500MG/VIALNoNo
002DEFEROXAMINE MESYLATEDEFEROXAMINE MESYLATEINJECTABLE;INJECTION2GM/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
47781-623Deferoxamine mesylateDeferoxamine mesylateAlvogen Inc.ANDACurrent
47781-623Deferoxamine mesylateDeferoxamine mesylateAlvogen Inc.ANDACurrent
47781-624Deferoxamine mesylateDeferoxamine mesylateAlvogen Inc.ANDACurrent
47781-624Deferoxamine mesylateDeferoxamine mesylateAlvogen Inc.ANDACurrent
47781-624Deferoxamine mesylateDeferoxamine mesylateAlvogen Inc.ANDACurrent
47781-624Deferoxamine mesylateDeferoxamine mesylateAlvogen Inc.ANDACurrent
52609-4504Deferoxamine mesylateDeferoxamine mesylateApoPharma USA, Inc.ANDACurrent
52609-4505Deferoxamine mesylateDeferoxamine mesylateApoPharma USA, Inc.ANDACurrent
60505-6236Deferoxamine mesylateDeferoxamine mesylateApotex Corp.ANDACurrent
60505-6236Deferoxamine mesylateDeferoxamine mesylateApotex Corp.ANDACurrent
60505-6237Deferoxamine mesylateDeferoxamine mesylateApotex Corp.ANDACurrent
60505-6237Deferoxamine mesylateDeferoxamine mesylateApotex Corp.ANDACurrent
60505-6238Deferoxamine mesylateDeferoxamine mesylateApotex Corp.ANDACurrent
68083-172Deferoxamine mesylateDeferoxamine mesylateGland Pharma LimitedANDACurrent
68083-173Deferoxamine mesylateDeferoxamine mesylateGland Pharma LimitedANDACurrent